Rotate your device

Please rotate your device to landscape mode
for the best experience.

AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gliminyle MV Plus 2mg/500mg/0.3mg Tablet

Prescription Icon
Prescription Required

Marketer

Erinyle Pharma

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Gliminyle MV Plus 2mg/500mg/0.3mg Tablet

DiaBeta-Plus 2mg/500mg/0.3mg tablets are classified as antidiabetic medications, a combination therapy for adult-onset type 2 diabetes. This medication helps manage blood glucose levels. DiaBeta-Plus should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan, including diet, exercise, and weight control as recommended by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Prompt glucose intake (e.g., sugary foods, fruit juice) is vital. Alcohol consumption should be limited due to its hypoglycemic effect. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation. Regular blood glucose monitoring and periodic blood tests (blood cell counts, liver function) are recommended.

Primary Ingredients of Gliminyle MV Plus 2mg/500mg/0.3mg Tablet

There is no text provided to rephrase.

Uses of Gliminyle MV Plus 2mg/500mg/0.3mg Tablet

Managing type 2 diabetes

Major Benefits of Gliminyle MV Plus 2mg/500mg/0.3mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Gliminyle MV Plus 2mg/500mg/0.3mg tablets on an empty stomach.

Common Side effects of Gliminyle MV Plus 2mg/500mg/0.3mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Gliminyle MV Plus 2mg/500mg/0.3mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. Gliminyle MV Plus 2mg/500mg/0.3mg tablets should be administered on an empty stomach.

How Gliminyle MV Plus 2mg/500mg/0.3mg Tablet works:

Gliminyle MV Plus tablets (2mg/500mg/0.3mg) contain a triple-action formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Gliminyle MV Plus 2mg/500mg/0.3mg tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Gliminyle MV Plus 2mg/500mg/0.3mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Gliminyle MV Plus 2mg/500mg/0.3mg tablets while breastfeeding is likely inadvisable. Available evidence in humans indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Patients with kidney disease should likely avoid Gliminyle MV Plus 2mg/500mg/0.3mg Tablets due to potential safety concerns. Medical advice is recommended. Furthermore, its use is discouraged in individuals with severe kidney impairment.

LiverLiverCAUTION

Patients with liver impairment should use Gliminyle MV Plus 2mg/500mg/0.3mg tablets cautiously. Dosage modification may be necessary. Consult a physician. For those with mild to moderate liver disease, initiate treatment with a low dose; the medication is unsuitable for patients with severe hepatic dysfunction.

What if you forget to take Gliminyle MV Plus 2mg/500mg/0.3mg Tablet :

Should you forget to take your Gliminyle MV Plus 2mg/500mg/0.3mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Gliminyle MV Plus 2mg/500mg/0.3mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Medication

FAQs on Gliminyle MV Plus 2mg/500mg/0.3mg Tablet

Gliminyle MV Plus 2mg/500mg/0.3mg tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers post-meal glucose levels. This medication is not suitable for type 1 diabetes.
Gliminyle MV Plus 2mg/500mg/0.3mg Tablets may cause side effects such as low blood sugar, nausea, diarrhea, taste changes, gas, stomach pain, headache, rash, and respiratory infections.
Gliminyle MV Plus 2mg/500mg/0.3mg Tablets are contraindicated in patients allergic to any ingredient, those with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Gliminyle MV Plus 2mg/500mg/0.3mg tablets with alcohol is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Gliminyle MV Plus 2mg/500mg/0.3mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Gliminyle MV Plus 2mg/500...
126
MRP 154
18% off